for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised. State-of-the-art treatment of OAB in 1999 includes ...

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

Natural treatments for multiple sclerosis ... saw an improvement in muscle stiffness, memory, bladder control and urination frequency, and sleep. Using some herbal products, such as echinacea, may ...

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

A recent groundbreaking study revealed that an amnion/chorion (AC) bilayer product could treat interstitial cystitis/bladder ...

At this time there are no drugs approved in the United States to treat SUI. If you have both SUI and OAB (Mixed Incontinence), your health care provider may prescribe OAB drugs or treatments. These ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial ...

The researchers found that patients showed favorable responses using this treatment regimen. In bladder cancer group, only one out of seven patients experienced disease progression after a median ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.